Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

作者信息

Mizutani K, Tamada Y, Hara K, Tsuzuki T, Saeki H, Tamaki K, Matsumoto Y

出版信息

Br J Dermatol. 2004 Jul;151(1):235-7. doi: 10.1111/j.1365-2133.2004.06024.x.

DOI:10.1111/j.1365-2133.2004.06024.x

PMID:15270901

Abstract

摘要

相似文献

Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

Br J Dermatol. 2004 Jul;151(1):235-7. doi: 10.1111/j.1365-2133.2004.06024.x.

Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.

Anticancer Drugs. 2006 Nov;17(10):1223-5. doi: 10.1097/01.cad.0000231486.94191.65.

Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.

Dermatol Surg. 2006 Aug;32(8):1097-102. doi: 10.1111/j.1524-4725.2006.32236.x.

Imatinib mesylate treatment for a Chinese patient with metastatic and recurrent dermatofibrosarcoma protuberans: is sustained partial remission possible?

Eur J Cancer Prev. 2012 Nov;21(6):585-7. doi: 10.1097/CEJ.0b013e3283529b4a.

Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.

Dermatol Surg. 2006 Mar;32(3):456-9. doi: 10.1111/j.1524-4725.2006.32090.x.

J Eur Acad Dermatol Venereol. 2010 Feb;24(2):244-5. doi: 10.1111/j.1468-3083.2009.03404.x. Epub 2009 Aug 20.

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

J Clin Oncol. 2005 Feb 1;23(4):866-73. doi: 10.1200/JCO.2005.07.088.

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

J Clin Oncol. 2002 Sep 1;20(17):3586-91. doi: 10.1200/JCO.2002.01.027.

Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans.

Arch Dermatol. 2009 Jul;145(7):792-6. doi: 10.1001/archdermatol.2009.140.

Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate.

J Cutan Pathol. 2008 Nov;35(11):1003-6. doi: 10.1111/j.1600-0560.2007.00948.x. Epub 2008 Jun 9.

引用本文的文献

Advances in non-invasive imaging for dermatofibrosarcoma protuberans: A review.

Australas J Dermatol. 2024 Dec;65(8):610-620. doi: 10.1111/ajd.14366. Epub 2024 Oct 3.

Dermatofibrosarcoma protuberans: from translocation to targeted therapy.

Cancer Biol Med. 2015 Dec;12(4):375-84. doi: 10.7497/j.issn.2095-3941.2015.0067.

Neoadjuvant treatment of Dermatofibrosarcoma Protuberans of pancreas with Imatinib: case report and systematic review of literature.

Clin Sarcoma Res. 2014 Aug 6;4:8. doi: 10.1186/2045-3329-4-8. eCollection 2014.

Imatinib: a breakthrough of targeted therapy in cancer.

Chemother Res Pract. 2014;2014:357027. doi: 10.1155/2014/357027. Epub 2014 May 19.

Targeting the PDGF signaling pathway in tumor treatment.

Cell Commun Signal. 2013 Dec 20;11:97. doi: 10.1186/1478-811X-11-97.

Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report.

Clin Sarcoma Res. 2013 Apr 4;3(1):5. doi: 10.1186/2045-3329-3-5.

Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT).

Sultan Qaboos Univ Med J. 2012 Aug;12(3):371-4. Epub 2012 Jul 15.

Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.

Sarcoma. 2011;2011:959132. doi: 10.1155/2011/959132. Epub 2011 Mar 30.

Reconstructive challenge of dermatofibrosarcoma protuberans in the female breast.

World J Surg Oncol. 2011 Jan 7;9:1. doi: 10.1186/1477-7819-9-1.

Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

J Clin Oncol. 2010 Apr 1;28(10):1772-9. doi: 10.1200/JCO.2009.25.7899. Epub 2010 Mar 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验